Abstract:Recently studied N-(β-d-glucopyranosyl)-3-aryl-1,2,4-triazole-5-carboxamides have proven to be low micromolar inhibitors of glycogen phosphorylase (GP), a validated target for the treatment of type 2 diabetes mellitus. Since in other settings, the bioisosteric replacement of the 1,2,4-triazole moiety with imidazole resulted in significantly more efficient GP inhibitors, in silico calculations using Glide molecular docking along with unbound state DFT calculations were performed on N-(β-d-glucopyranosyl)-arylimidazole-carboxamides, revealing their potential for strong GP inhibition. The syntheses of the target compounds involved the formation of an amide bond between per-O-acetylated β-d-glucopyranosylamine and the corresponding arylimidazole-carboxylic acids. Kinetics experiments on rabbit muscle GPb revealed low micromolar inhibitors, with the best inhibition constants (Kis) of ~3–4 μM obtained for 1- and 2-naphthyl-substituted N-(β-d-glucopyranosyl)-imidazolecarboxamides, 2b–c. The predicted protein–ligand interactions responsible for the observed potencies are discussed and will facilitate the structure-based design of other inhibitors targeting this important therapeutic target. Meanwhile, the importance of the careful consideration of ligand tautomeric states in binding calculations is highlighted, with the usefulness of DFT calculations in this regard proposed.

Synthesis and Biological Evaluation of Substituted Phenylpyrazole[4,5-B]oleanane Derivatives As Inhibitors of Glycogen Phosphorylase.

Synthesis and biological evaluation of novel pyrazolo[4,3-b]oleanane derivatives as inhibitors of glycogen phosphorylase.

Synthesis Of 3-Deoxypentacyclic Triterpene Derivatives As Inhibitors Of Glycogen Phosphorylase

Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase

Synthesis and Biological Activity of Heterocycle-Fused Derivatives of Pentacylic Triterpenes As Glycogen Phosphorylase Inhibitors

Pentacyclic Triterpenes. Part 5: Synthesis and SAR Study of Corosolic Acid Derivatives As Inhibitors of Glycogen Phosphorylases.

Synthesis and Biological Evaluation of Ursolic Acid Derivatives As Novel Inhibitors of Glycogen Phosphorylase

Synthesis and biological evaluation of asiatic acid derivatives as inhibitors of glycogen phosphorylases.

Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies.

Pentacyclic triterpenes. Part 2: Synthesis and biological evaluation of maslinic acid derivatives as glycogen phosphorylase inhibitors.

Synthesis and Biological Evaluation of Arjunolic Acid, Bayogenin, Hederagonic Acid and 4-Epi-hederagonic Acid as Glycogen Phosphorylase Inhibitors

Synthesis and Evaluation of 3-Anilino-quinoxalinones As Glycogen Phosphorylase Inhibitors.

Identification of Pentacyclic Triterpenes Derivatives As Potent Inhibitors Against Glycogen Phosphorylase Based on 3D-QSAR Studies

Synthesis, In Silico and Kinetics Evaluation of N-(β-d-glucopyranosyl)-2-arylimidazole-4(5)-carboxamides and N-(β-d-glucopyranosyl)-4(5)-arylimidazole-2-carboxamides as Glycogen Phosphorylase Inhibitors

In the Search of Glycogen Phosphorylase Inhibitors: Synthesis of C-D-Glycopyranosylbenzo(hydro)quinones – Inhibition of and Binding to Glycogen Phosphorylase in the Crystal

Terpenoids. III: Synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase.

Synthesis of glucoconjugates of oleanolic acid as inhibitors of glycogen phosphorylase.

Synthesis and Biological Evaluation of Novel Pentacyclic Triterpene Derivatives As Potential PPARγ Agonists

Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme.

Synthesis of oleanolic acid dimers as inhibitors of glycogen phosphorylase.

Synthesis and Evaluation of C-28 Oleanolic Acid Derivatives As Inhibitors of Glycogen Phosphorylase